- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Editors of AJMC® Wrap Up the Year and Look to 2024
The editors in chief of The American Journal of Managed Care® discuss the managed care developments of 2023 and anticipate trends on the horizon.
On this episode of Managed Care Cast, we’re talking with the co–editors in chief of The American Journal of Managed Care® (AJMC®), Mark Fendrick, MD, and Michael Chernew, PhD. They look back on the past year and discuss what they’re looking forward to in 2024.
Check out the editors’ favorite AJMC research of 2023:
Characterizing Obesity in a Large Health Care Delivery System
Provider Directory Inaccuracy and Timely Access for Mental Health Care
Income Differences Between Locations of 340B Entities and Contract Pharmacies
Medicare Advantage in Rural Areas: Implications for Hospital Sustainability
ICYMI: Highlights From AMCP Nexus 2024
December 26th 2024Check out this year's top coverage from The Academy of Managed Care Pharmacy (AMCP) Nexus 2024 meeting, which included relevant topics in health care policy, novel pharmaceutical developments, financial considerations across multiple conditions, and more.
Read More
Year-End Spending Bill to Feature Reforms for Pharmacy Benefit Managers and Telehealth Access
December 18th 2024The health care provisions include key reforms targeting pharmacy benefit managers, extensions of Medicare telehealth flexibilities, and measures aimed at combating the opioid crisis and preparing for future pandemics.
Read More
Managed Care Cast Presents: BTK Inhibitors in Treatment-Naive Patients With CLL and MCL
December 26th 2024A trio of experts discuss the treatment of chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL) with Bruton tyrosine kinase (BTK) inhibitors, including cost considerations.
Listen
